STOCK TITAN

Insulet Corp Stock Price, News & Analysis

PODD Nasdaq

Welcome to our dedicated page for Insulet news (Ticker: PODD), a resource for investors and traders seeking the latest updates and insights on Insulet stock.

Insulet Corporation (PODD) delivers innovative diabetes management solutions through its flagship Omnipod® insulin pump system. This page aggregates official news and developments about the company's medical device innovations, financial performance, and strategic initiatives.

Investors and healthcare professionals will find timely updates including quarterly earnings reports, product launch announcements, regulatory milestones, and partnership agreements. All content is sourced directly from verified corporate communications to ensure accuracy.

Key coverage areas include FDA clearances for new devices, clinical study results, international market entries, and technology partnerships enhancing insulin delivery systems. The resource is particularly valuable for tracking advancements in tubeless pump technology and automated insulin dosing integrations.

Bookmark this page for streamlined access to Insulet's latest developments in diabetes care innovation. Check regularly for updates that may impact long-term growth strategies or patient care standards.

Rhea-AI Summary

Insulet (NASDAQ: PODD) reported a 23% year-over-year revenue increase in the first quarter of 2024, with total revenue reaching $441.7 million. The Company exceeded its guidance range due to revenue outperformance across all product lines. Gross margin increased to 69.5%, operating income rose to $56.9 million, and net income reached $51.5 million. Insulet also achieved strong new customer starts, expanded market share globally, and launched new products like Omnipod 5 integrated with Dexcom's G7 sensor. The company is raising its full-year revenue and operating margin guidance for 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.55%
Tags
-
Rhea-AI Summary

Insulet (NASDAQ: PODD) released its 2023 Sustainability Report highlighting achievements in environmental, social, and governance areas. The report focuses on product accessibility, responsible growth, affordability, resilient operations, and sustainable product innovation. Insulet reached 425,000 active global customers, expanded financial assistance programs, generated renewable energy, reduced waste, and enhanced product sustainability. The company conducted a comprehensive double materiality assessment to prioritize initiatives and ensure operational resilience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.47%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
none

FAQ

What is the current stock price of Insulet (PODD)?

The current stock price of Insulet (PODD) is $291.51 as of December 15, 2025.

What is the market cap of Insulet (PODD)?

The market cap of Insulet (PODD) is approximately 20.8B.
Insulet Corp

Nasdaq:PODD

PODD Rankings

PODD Stock Data

20.80B
70.13M
0.27%
101.79%
2.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON